FTC Contests Impax's Defense Of Opana ER Patent Settlement
Impax Laboratories Inc. has no pro-competitive justifications for its 2010 patent dispute settlement with Endo Pharmaceuticals Inc. over the drug Opana ER, and none of its defenses of the agreement's alleged...To view the full article, register now.
Already a subscriber? Click here to view full article